AIRSEAL
Device
CONMED Corporation
Total Payments
$3.7M
Transactions
7,706
Doctors
4,916
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $711,772 | 2,210 | 1,697 |
| 2023 | $598,485 | 1,734 | 1,326 |
| 2022 | $819,282 | 1,610 | 1,077 |
| 2021 | $533,587 | 638 | 448 |
| 2020 | $480,920 | 369 | 274 |
| 2019 | $597,593 | 1,145 | 924 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $1.2M | 62 | 32.0% |
| Consulting Fee | $789,500 | 252 | 21.1% |
| Long term medical supply or device loan | $475,498 | 218 | 12.7% |
| Food and Beverage | $379,425 | 6,782 | 10.1% |
| Grant | $285,912 | 57 | 7.6% |
| Travel and Lodging | $217,585 | 279 | 5.8% |
| Space rental or facility fees (teaching hospital only) | $210,001 | 24 | 5.6% |
| Debt forgiveness | $96,548 | 3 | 2.6% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $43,250 | 10 | 1.2% |
| Compensation for serving as faculty or as a speaker for a medical education program | $32,875 | 13 | 0.9% |
| Education | $13,329 | 5 | 0.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,000 | 1 | 0.1% |
Payments by Type
General
$2.5M
7,644 transactions
Research
$1.2M
62 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| LAPAROSCOPIC HERNIA | CONMED Corporation | $285,000 | 1 |
| SurgiQuest AirSeal in Robotic Partial Nephrectomy | CONMED Corporation | $200,846 | 1 |
| AIRSEAL PEDIATRIC CLINICAL QUALITY IMPROVEMENT INITIATIVE | CONMED Corporation | $131,500 | 2 |
| A PROSPECTIVE REGISTRY FOR ROBOTIC UROLOGIC SURGERIES PERFORMED FOR THE TREATMENT OF BLADDER CANCER, RENAL CANCER, PROSTATE CANCER, AND UPPER TRACT UROLOGIC CONDITIONS AT AN AMBULATORY SURGERY CENTER WITH PLANNED SAME-DAY DISCHARGE | CONMED Corporation | $105,000 | 0 |
| A PROSPECTIVE REGISTRY FOR ROBOTIC UROLOGIC SURGERIES PERFORMED FOR THE TREATMENT OF BLADDER CANCERA Prospective Registry for Robotic Urologic Surgeries Performed for the Treatment of Bladder Cancer, Renal Cancer, Prostate Cancer, and Upper Tract Urologic Conditions at an Ambulatory Surgery Center with Planned Same-Day Discharge | CONMED Corporation | $75,000 | 1 |
| Randomized Study of Ultralow Versus Standard Pneumoperitoneum Pressure During Robotic Prostatectomy Using the AirSeal Insufflation System | CONMED Corporation | $53,468 | 2 |
| A Randomized-Controlled Trial of Conventional Pneumoinsufflators and a Pressure Barrier Insufflator at High and Low Pressures in Gynecologic Surgery | CONMED Corporation | $51,890 | 0 |
| Laparoscopic Hernia | CONMED Corporation | $50,000 | 1 |
| Risk of aerosolization of COVID-19 during surgery | CONMED Corporation | $48,010 | 1 |
| PEDS Clinical Quality Improvement | CONMED Corporation | $40,000 | 1 |
| PEDS CLINICAL QUALITY IMPROVEMENT | CONMED Corporation | $30,000 | 1 |
| A Prospective Registry for Robotic Urologic Surgeries Performed for the Treatment of Bladder Cancer, Renal Cancer, Prostate Cancer, and Upper Tract Urologic Conditions at an Ambulatory Surgery Center with Planned Same-Day Discharge | CONMED Corporation | $25,000 | 1 |
| LAPAROSCOPIC HERNIA | Linvatec Corporation | $25,000 | 1 |
| Low Pressure Pneumoperitoneum a Key Component of Opiod-Sparing Surgery | CONMED Corporation | $25,000 | 1 |
| Multicenter Phase II Study of Transanal Total Mesorectal Excision -taTME- with Laparoscopic Assistance for Rectal Cancer | CONMED Corporation | $25,000 | 0 |
| Multicenter Phase III taTME Study | CONMED Corporation | $25,000 | 1 |
Top Doctors Receiving Payments for AIRSEAL
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Oak Lawn, IL | $1.2M | 283 |
| , MD | Surgery | Daytona Beach, FL | $575,861 | 60 |
| , M.D | Surgery | Tomball, TX | $419,232 | 271 |
| , MD | Pediatric Surgery | Cincinnati, OH | $206,472 | 34 |
| , M.D | Urology | Dublin, OH | $163,085 | 38 |
| , MD | Gynecologic Oncology | Miami, FL | $131,778 | 37 |
| , M.D | Urology | New York, NY | $130,532 | 8 |
| , M.D | Surgery | Greeley, CO | $56,339 | 57 |
| , M.D | Surgery | Winter Park, FL | $54,817 | 39 |
| , M.D | Urology | New York, NY | $48,241 | 7 |
| , M.D | Obstetrics & Gynecology | Roseville, CA | $45,730 | 38 |
| , M.D | Colon & Rectal Surgery | Houston, TX | $32,618 | 14 |
| , M.D | Surgery | Plano, TX | $28,922 | 71 |
| , M.D | Surgery | Boston, MA | $25,000 | 1 |
| , M.D | Vascular Surgery | Hartford, CT | $25,000 | 1 |
| , M.D | Surgery | Tampa, FL | $21,157 | 26 |
| , MD | Surgery | Charleston, SC | $20,344 | 10 |
| , MD | Colon & Rectal Surgery | Altamonte Springs, FL | $19,956 | 17 |
| , M.D | Surgery | Atlanta, GA | $14,378 | 18 |
| , M.D | Obstetrics & Gynecology | New York, NY | $13,465 | 6 |
| , MD | Urology | Philadelphia, PA | $11,500 | 4 |
| , MD | Gynecologic Oncology | Baltimore, MD | $10,200 | 3 |
| , M.D | Thoracic Surgery (Cardiothoracic Vascular Surgery) | Plano, TX | $10,146 | 6 |
| , M.D | Surgery | Orlando, FL | $9,038 | 13 |
| , M.D | Surgery | Durham, NC | $8,735 | 7 |
Ad
Manufacturing Companies
- CONMED Corporation $3.2M
- Linvatec Corporation $558,785
Product Information
- Type Device
- Total Payments $3.7M
- Total Doctors 4,916
- Transactions 7,706
About AIRSEAL
AIRSEAL is a device associated with $3.7M in payments to 4,916 healthcare providers, recorded across 7,706 transactions in the CMS Open Payments database. The primary manufacturer is CONMED Corporation.
Payment data is available from 2019 to 2024. In 2024, $711,772 was paid across 2,210 transactions to 1,697 doctors.
The most common payment nature for AIRSEAL is "Unspecified" ($1.2M, 32.0% of total).
AIRSEAL is associated with 16 research studies, including "LAPAROSCOPIC HERNIA" ($285,000).